A compendium of antihypertensive therapy

Journal of Clinical Hypertension

Volumn 13, Issue 9, 2011, Pages 636-638

  Ferdinand, Keith C ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Atlanta Clinical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALDOSTERONE ANTAGONIST; ALISKIREN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CHLORTALIDONE; CLONIDINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; EPLERENONE; GUANABENZ; GUANFACINE; LABETALOL; LOOP DIURETIC AGENT; LOSARTAN; NEBIVOLOL; POTASSIUM SPARING DIURETIC AGENT; PRAZOSIN; RENIN INHIBITOR; SPIRONOLACTONE; TELMISARTAN; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; ADD ON THERAPY; ADULT; AFRICAN AMERICAN; AGED; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CHRONIC DISEASE; CLINICAL PRACTICE; COUGHING; DIABETIC PATIENT; DIURETIC THERAPY; DROWSINESS; DRUG APPROVAL; DRUG CHOICE; DRUG CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; EDITORIAL; ETHNIC GROUP; FATIGUE; FEMALE; GERIATRIC PATIENT; GLUCOSE INTOLERANCE; GYNECOMASTIA; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; MALE; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL SPECIALIST; MENSTRUAL IRREGULARITY; MONOTHERAPY; PATIENT COMPLIANCE; POLYPHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE; TREATMENT OUTCOME; UNITED STATES; XEROSTOMIA;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; RENIN; SODIUM CHLORIDE SYMPORTER INHIBITORS; SYMPATHOLYTICS; TREATMENT OUTCOME;

EID: 80052552642     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00506.x     Document Type: Editorial

References (10)

1. Sica DA, Carter B, Cushman W, et al. Thiazide and loop diuretics. J Clin Hypertens (Greenwich). 2011;13:639-643.
2. Epstein M, Calhoun DA. Aldosterone blockers and potassium-sparing diuretics. J Clin Hypertens (Greenwich). 2011;13:644-648.
3. Frishman WR, Saunders E. Beta-adrenergic blockers. J Clin Hypertens (Greenwich). 2011;13:649-653.
4. Grimm RH, Flack JM. Alpha 1 adrenoreceptor antagonists. J Clin Hypertens (Greenwich). 2011;13:654-657.
5. Vongpatanasin W, Kario K, Atlas SA, et al. Central sympatholytic drugs. J Clin Hypertens (Greenwich). 2011;13:658-661.
6. Fisher NDL, Meagher EA. Renin inhibitors. J Clin Hypertens (Greenwich). 2011;13:662-666.
7. Izzo JL, Weir MR. Angiotensin-converting enzyme inhibitors. J Clin Hypertens (Greenwich). 2011;13:667-675.
8. Taylor AA, Siragy H, Nesbitt SD. Angiotensin receptor blockers: pharmacology, efficacy and safety. J Clin Hypertens (Greenwich). 2011;13:677-686.
9. Elliott WJ, Ram CVS. Calcium channel blockers. J Clin Hypertens (Greenwich). 2011;13:687-689.
10. Cohn JN, McInnes GT, Shepherd AM. Direct-acting vasodilators. J Clin Hypertens (Greenwich). 2011;13:690-692.